Search for: "NOVARTIS PHARMA GMBH"
Results 1 - 11 of 11
Sorted by Relevance | Sort by Date
31 Oct, 2008 11:53 am
... : implications for life sciences companies (part 2) (Pharmacapsules @ Gowlings) Botswana and South Africa to benefit from pharma grant from
Gates Foundation (Afro-IP) Canada: University of manitoba licenses gene discovery linked to increase in ... Harmonisation in the Internal Market, Nycomed GmbH, an appeal involving a Community trade mark opposition to PRAZOL (Managing Intellectual Property) ReFacto / Xyntha (Antihemophilic Factor Recombinant) -
US: Novartis files amended complaint against Wyeth ...
6 Feb 5:00 am
... diseases - can it be done for less? (IP finance) Pharmaceutical Technology article on barriers to entry for generic pharma companies based
in emerging economies (Afro-IP) The effects of IP protection on agricultural research: Patents are not the ... US: Applied Genetic Technologies sues Genzyme claiming IP misappropriation
as gene therapy pact falls apart (Law360) US: Novartis files amicus brief supporting Prometheus and the patentability of personalised medicine
claims: Prometheus v Mayo (Holman's ...
25 Oct, 2008 12:03 am
... Antitrust Litigation (IP Law Observer) Lescol (Fluvastatin) - US: Mylan confirms first-to-file patent challenge to Lescol by Novartis
(SmartBrief) Levaquin (Levofloxacin) - UK: Levofloxacin SPC valid: Generics (UK) Ltd v Daiichi Pharmaceutical Co Ltd & ... (Omeprazole) - EU: Court of First Instance hands down in
decision in Aventis Pharma SA v Office for Harmonisation in the Internal Market, Nycomed GmbH, an
appeal involving a Community trade mark opposition to PRAZOL (IPKat) Sustiva (Efavirenz ...
30 Aug 10:00 pm
... ) sued Novartis Pharmaceuticals (a Delaware corporation with its principal place of business in New Jersey), Novartis Pharma GmbH (a German corporation), and Novartis AG (a Swiss corporation) in New Jersey state court. Diversity thus existed (Texas ... removable if a party "joined and served" as a defendant is a
"citizen of the State in which such action is brought." Novartis thus removed the action before plaintiff had served the resident defendant
with the complaint. Although courts have split on ...
22 Feb, 2008 6:00 pm
... its ofloxacin patent infringement case against Apotex: (IP Law360), Galvus (Vildagliptin) - Indian patent granted to Novartis for
anti-diabetic drug Vildagliptin: (Patent Circle), Isentress (Raltegravir) - Indian patent granted to Merck for ... Intellectual Property Watch), (GenericsWeb), Taxotere (Docetaxel) -
Thailand Government Pharmaceutical Organisation signs deal with Dabur Pharma to distribute generic breast and lung cancer treatment in Thailand
despite uncertainty over compulsory licensing in ...
1 Feb, 2008 12:00 am
... RNA interference: (SmartBrief), Doha style compulsory licences for exports: The politics…: (Spicy IP), Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP), Financial Express on the battle between big pharma companies
and the ... Pharmaceuticals & IP), (Spicy IP), Glivec (Imanitib):Thailand avoids compulsory licence on cancer drug with Novartis agreeing
to provide the drug free under a government-sponsored health insurance program: (Intellectual Property Watch), ...
18 Jul, 2008 8:34 am
... generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular
(Ketorolac) - US: CAFC rules against Apotex ... infringement suit against Momenta/Sandoz over generic Copaxone ANDA: Momenta, Novartis
challenge Teva's Copaxone patent: (Philip Brooks), (The IP Factor), (SmartBrief), ... (Out-Law) CFI rejects MOZART for chocolate on grounds of descriptiveness: Paul Reber
GmbH v OHIM: (The IP Factor) France Appellate court upholds fine of €50 ...
28 Apr, 2008 11:00 am
... , Northwest end patent wrangle over gene expression technology: (IP Law360) Pharma & Biotech - Products Aerius (Desloratadine) -
Canada: Court grants Pharmascience's ... second patent eligible for listing so should proceeds to hearing on the merits: Nycomed GmbH and
Nycomed Canada Inc v Minister of Health and Genpharm Inc: ... (International Law Office), Yasmin (Drospirenone) - US: Bayer sues Watson Pharma
and Novartis to prevent generic version of Yasmin: (IP Law360), (GenericsWeb) Africa WIPO DG ...
4 Apr, 2008 1:00 am
... out wrong' about BIO position on follow-on biologics: (GenericsWeb), US: Ugliness in the WARF patent re-examination?: (IPBiz) Pharma &
Biotech - Products Abilify (Aripiprazole) - Otsuka files US patent infringement suit against Teva over seeking approval ... subpoenas in US patent litigation: (IP Law360), Exjade
(Deferasirox) - CIPLA set to launch generic Deferasirox in India; Novartis has applied for an Indian patent on Deferasirox and plans to launch
Exjade in second quarter 2008: (Spicy IP), ...
11 Apr, 2008 9:00 am
... tumours can cover subjects beyond USPTO interference proceeding: (IP Law360) Pharma & Biotech - Products Actonel (Risedronate) -
Proctor & Gamble files third ... UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) - Dr Reddy's and Novartis settle Exelon patent
dispute: (Therapeutics Daily), GeneMaker - Codon Devices, Blue ... Bundespatentgericht references to ECJ in BILB.T-ONLINE and ZVS Zeitungsvertrieb Suttgart GmbH: (Class 46) India Ongoing issues with Basmati GI: (Spicy IP), Bumper ...
2 Aug, 2008 12:54 am
... holds hearing on drug pricing; GPhA lobbies for follow-on biologics pathway: (Patent Docs) Pharma & Biotech - Products Aciphex
(Rabeprazole) - US: Eisai patent survives obviousness claim ... of UCB's Xyzal patent: (Law360), (GenericsWeb), Zometa (Zoledronic acid) - US: Novartis sues Teva over generic Zometa ANDA: (Law360) Australia Export market ... ), Nike terminates sponsorship deal with footballer Joey Barton: (Class 46),
Minimax GMBH & Co v. Chubb Fire Ltd: (IPKat), 70 Positives for PDCO in ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!